The Armstrong Lie (2013) Timeline Explained – Every Event in Order

Armstrong started using EPO and other performance-enhancing drugs beginning in 1995 to remain competitive, as doping had become widespread in European cycling during the 1980s and 1990s. His team doctor Michele Ferrari convinced him that EPO was necessary because it was undetectable in urine tests at the time, and other top cyclists were already using it. This decision was driven by the belief that he could not win against doped competitors without taking the same substances.

• lance armstrong
• ep o
• doping
• performance enhancing drugs
• Michele Ferrari
• tour de france

Armstrong evaded detection for years through a sophisticated system designed by team doctor Michele Ferrari. Ferrari used methods like micro-dosing EPO to stay below detection thresholds and arranged blood transfusions, removing blood before races and reintroducing it just before competition to boost red blood cell counts without leaving traces. Additionally, Ferrari had connections with UCI's drug testing labs that helped ensure Armstrong's samples remained below suspicion levels.

• lance armstrong
• drug tests
• evasion
• Michele Ferrari
• blood transfusion
• doping detection

Michele Ferrari was Armstrong's team doctor who designed and administered the doping program from 1995 onward. He created strategies including switching to lower gears in mountains to reduce muscle strain while using EPO to increase oxygen-carrying capacity in blood. Ferrari also helped manipulate drug tests by ensuring Armstrong's use remained below detection thresholds. He was convicted of sports fraud in 2004, yet Armstrong continued working with him and publicly distanced himself.

• Michele Ferrari
• team doctor
• doping program
• EPO
• sports fraud

Despite evidence of Armstrong's doping, his 1999 urine sample had tested positive for EPO, the UCI permitted him to compete in the 2009 Tour de France. This occurred because the UCI leadership, particularly president Hein Verbruggen, had vested financial interests in maintaining Armstrong's image as a clean champion. The UCI had overlooked the 1999 EPO findings and subsequently shielded Armstrong from scrutiny, allowing his comeback despite mounting evidence of misconduct.

• 2009 tour de france
• UCI
• Hein Verbruggen
• doping evidence
• competition ban

Armstrong's downfall was triggered by a combination of factors converging in 2012. Former teammates who had been turned away from his 2009 team began testifying against him, providing firsthand accounts of witnessing his drug use. The French article "The Armstrong Lie" published evidence showing his 1999 urine sample contained EPO. As media scrutiny intensified, Armstrong's legal attempts to silence accusers failed, and the UCI ultimately stripped all seven Tour de France titles and issued a lifetime ban in October 2012.

• lance armstrong downfall
• testimony
• investigation
• stripping titles
• 2012

Several factors motivated former teammates to testify against Armstrong. Some, like Frankie Andreu, had already testified in 2006 and faced ostracism from the cycling community as a result. Others were turned away from Armstrong's 2009 team when he sought to present a "clean team" image, despite knowing the full extent of his drug use. Betsy, Frankie's wife, became particularly obsessed with exposing Armstrong's deception and rallied other former teammates to form a coalition against him.

• former teammates
• testimony
• Frankie Andreu
• Betsy Andreu
• coalition

Following his 2013 Oprah interview confession, Armstrong faced severe legal and financial consequences. The US Postal Service, his sponsor during his Tour de France wins, filed a $100 million lawsuit for fraud and false advertising. The World Anti-Doping Agency issued a lifetime ban from all sports. His legacy was completely destroyed, with all seven Tour de France titles permanently stripped, and he was left facing massive financial liability and public disgrace.

• oprah interview
• confession
• lawsuit
• 100 million
• lifetime ban
• US Postal Service

Armstrong returned in 2009 primarily to silence critics who questioned the legitimacy of his seven Tour de France titles. He wanted to prove he could win clean and validate his earlier accomplishments. However, his comeback ultimately contributed to his downfall, during the 2009 race, a former teammate who had been turned away from his team played a role in exposing the truth, and the scrutiny from that comeback reignited investigations that led to his 2012 confession.

• 2009 comeback
• tour de france
• motivation
• critics
• validation

Yes, evidence suggests significant UCI complicity in overlooking Armstrong's doping. UCI president Hein Verbruggen had mutual financial interests in maintaining Armstrong's image as a champion. The organization failed to act on the 1999 EPO discovery and allowed Armstrong to compete in 2009 despite mounting evidence. Questions arose about whether Verbruggen's decisions were influenced by financial arrangements that benefited both the UCI and Armstrong's marketability.

• UCI
• Hein Verbruggen
• cover up
• complicit
• corruption
• investigation

Armstrong's 1999 testicular cancer diagnosis, which had spread to his lungs and brain, forced him to undergo experimental treatment including testicle removal, brain surgery, and chemotherapy. Surviving this aggressive cancer became the foundation of his inspirational comeback narrative. His 1999 Tour de France victory was remarkable because he had not been recognized as a strong climber before his illness, and his performance as a cancer survivor defied medical expectations, later fueling suspicions about possible doping enhancement.

• testicular cancer
• chemotherapy
• cancer survivor
• tour de france victory
• 1999